Invention Grant
- Patent Title: Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
-
Application No.: US13661897Application Date: 2012-10-26
-
Publication No.: US08455653B2Publication Date: 2013-06-04
- Inventor: Ulrich Kautz
- Applicant: Nycomed GmbH
- Applicant Address: DE Konstanz
- Assignee: Takeda GmbH
- Current Assignee: Takeda GmbH
- Current Assignee Address: DE Konstanz
- Agency: Nath, Goldberg & Meyer
- Agent Sheldon M. McGee
- Priority: EP04004973 20040303; EP04106359 20041207
- Main IPC: C07D211/68
- IPC: C07D211/68 ; C07D211/80 ; A01N43/42 ; A61K31/44
Abstract:
Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of psoriasis.
Public/Granted literature
- US20130045974A1 NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS Public/Granted day:2013-02-21
Information query
